This report discusses US ethical pharmaceuticals for the years 2000 and 2005, with forecasts to 2010. Topics covered include market size, distribution and commercial status, product segmentation, regulatory considerations, market environment, distribution and commercial status forecasts, product forecasts, industry composition and leading participants. Product segments cover cardiovascular agents, central nervous system agents, anti-infective agents, gastrointestinal agents, respiratory agents, and other agents. Pharmaceutical demand by distribution status (ethical and over-the-counter) and commercial status (proprietary and generic) is also included. This 17 page report also includes a highlights summary and resources section.

Companies Profiled

GlaxoSmithKline
Johnson & Johnson
Pfizer Incorporated

Table of Contents

HIGHLIGHTS

INDUSTRY OVERVIEW
Market Size
Distribution & Commercial Status
Product Segmentation
Regulatory Considerations

INDUSTRY TRENDS & FORECASTS
Market Environment
Distribution & Commercial Status Forecasts
Product Forecasts

INDUSTRY STRUCTURE
Industry Composition
Industry Leaders

RESOURCES

Focus Report Overview

Each Freedonia Focus provides access to a wealth of industry insights and analysis

For more information, please visit:
http://www.bharatbook.com/detail.asp?id=8689

####